NCT01167946
- Conditions
- Alopecia, Alopecia Areata, Alopecia Totalis, +7 more
- Locations
-
- King Khalid University Hospital Riyadh, Riyadh Region, Saudi Arabia
Clinical trial condition
Hypotrichosis
Explore clinical trials studying Hypotrichosis. Study availability and eligibility vary by location and protocol.
452 public trials
73 recruiting studies
Hypotrichosis trial results
NCT01052870
- Conditions
- Alopecia, Androgenetic Alopecia, Bulbo-Spinal Atrophy, X-Linked, +17 more
- Locations
-
Not specified
NCT00965640
- Conditions
- Alopecia, Hair Diseases, Hypotrichosis, +5 more
- Locations
-
- Crown Institute Pickering, Ontario, Canada
NCT00176982
- Conditions
- Alopecia, Alopecia Areata, Hair Diseases, +3 more
- Locations
-
- University of Minnesota Minneapolis, Minnesota, United States
- State University of New York at Stony Brook Stony Brook, New York, United States
NCT00418730
- Conditions
- Alopecia, Androgenetic Alopecia, Hair Diseases, +5 more
- Locations
-
- bioskin Institute for Dermatological Research and Development GmbH Hamburg, Germany
NCT00177099
- Conditions
- Alopecia, Hair Diseases, Hypotrichosis, +4 more
- Locations
-
- University of Minnesota Minneapolis, Minnesota, United States
NCT00177021
- Conditions
- Alopecia, Alopecia Areata, Hair Diseases, +3 more
- Locations
-
- University of Minnesota Minneapolis, Minnesota, United States
Active, Not Recruiting
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata
NCT07023302
- Conditions
- Alopecia, Alopecia Areata, Hair Diseases, +3 more
- Locations
-
- Nagoya City University Hospital /ID# 275409 Nagoya, Aichi-ken, Japan
- Kurume University Hospital /ID# 275519 Kurume-shi, Fukuoka, Japan
- Kanazawa Medical University Hospital /ID# 275521 Kahoku-gun, Ishikawa-ken, Japan
- Nagomi Dermatology Clinic /ID# 275418 Ebina-shi, Kanagawa, Japan
Active, Not Recruiting
A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)
NCT06799520
- Conditions
- Alopecia, Alopecia Areata, Alopecia Areata (AA), +10 more
- Locations
-
- Visterra Investigational Site Sofia, Bulgaria
- Visterra Investigational Site Chisinau, Moldova
- Visterra Investigational Site Bucharest, Romania
- Visterra Investigational Site Cluj-Napoca, Romania
Active, Not Recruiting
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)
NCT06340360
- Conditions
- Alopecia, Alopecia Areata, Hair Diseases, +3 more
- Locations
-
- Nektar Investigative Site Northridge, California, United States
- Nektar Investigative Site Atlanta, Georgia, United States
- Nektar Investigative Site Gurnee, Illinois, United States
- Nektar Investigative Site Indianapolis, Indiana, United States